Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
McGill University
$27,000.00
Investigating the role of lipid droplets in drug-tolerant persister cells in triple-negative breast cancer
EF 2025-26
Résumé
An estimated 30,500 Canadian women were diagnosed with breast cancer in 2024, which makes it the most commonly diagnosed cancer in this demographic. A particular type of breast cancer called triple-negative breast cancer (TNBC) is exceptionally aggressive. Sometimes, chemotherapy treatment fails to produce a complete response, and a residual amount of the tumor remains. This residual disease puts the patient at risk of a relapse. My proposed work describes a potential strategy to eliminate the TNBC cells that survive the chemotherapy.
One way that chemotherapy can affect cancer cells is by inducing an iron-dependent form of cell death known as ferroptosis. This process is characterized by damage to cellular membranes that contain polyunsaturated fatty acids. Fatty acids are found not only in membranes but also inside lipid droplets (in the form of triglycerides). I have observed elevated levels of lipid droplets in TNBC cells that were treated with chemotherapy. The lipid droplets may serve to shelter polyunsaturated fatty acids as a buffer to prevent cell death by ferroptosis in response to chemotherapy.
I am investigating how cancer cells form these lipid droplets to escape the damage caused by chemotherapy exposure. I am also interested in determining strategies to prevent the formation of lipid droplets because I hypothesize that this might sensitize TNBC cells to chemotherapy. To do this, I will use isolated TNBC cells (in vitro models) and TNBC patient tumor samples that have been implanted into mice (in vivo models). These experiments will establish the role of cellular metabolism and exposure to chemotherapy drugs in the formation of lipid droplets. This work could enable the future development of treatment strategies to prevent relapse in TNBC patients.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573305
Name
Topolski Jason D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of lipid droplets in drug-tolerant persister cells in triple-negative breast cancer
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Bodipy Dyes; Breast Cancer; Chemotherapy; Drug Tolerance; Ferroptosis; Lipid Droplets; Metabolism; Patient-Derived Xenografts; Polyunsaturated Fatty Acids; Residual Disease
Abstract
An estimated 30,500 Canadian women were diagnosed with breast cancer in 2024, which makes it the most commonly diagnosed cancer in this demographic. A particular type of breast cancer called triple-negative breast cancer (TNBC) is exceptionally aggressive. Sometimes, chemotherapy treatment fails to produce a complete response, and a residual amount of the tumor remains. This residual disease puts the patient at risk of a relapse. My proposed work describes a potential strategy to eliminate the TNBC cells that survive the chemotherapy.
One way that chemotherapy can affect cancer cells is by inducing an iron-dependent form of cell death known as ferroptosis. This process is characterized by damage to cellular membranes that contain polyunsaturated fatty acids. Fatty acids are found not only in membranes but also inside lipid droplets (in the form of triglycerides). I have observed elevated levels of lipid droplets in TNBC cells that were treated with chemotherapy. The lipid droplets may serve to shelter polyunsaturated fatty acids as a buffer to prevent cell death by ferroptosis in response to chemotherapy.
I am investigating how cancer cells form these lipid droplets to escape the damage caused by chemotherapy exposure. I am also interested in determining strategies to prevent the formation of lipid droplets because I hypothesize that this might sensitize TNBC cells to chemotherapy. To do this, I will use isolated TNBC cells (in vitro models) and TNBC patient tumor samples that have been implanted into mice (in vivo models). These experiments will establish the role of cellular metabolism and exposure to chemotherapy drugs in the formation of lipid droplets. This work could enable the future development of treatment strategies to prevent relapse in TNBC patients.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Topolski, Jason D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~